BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27588387)

  • 1. The usefulness of monitored therapy using Clozapine concentration in the blood serum for determining drug dose in Polish schizophrenic patients.
    Piwowarska J; Radziwoń-Zaleska M; Dmochowska M; Szepietowska E; Matsumoto H; Sygitowicz G; Pilc A; Łukaszkiewicz J
    Pharmacol Rep; 2016 Dec; 68(6):1120-1125. PubMed ID: 27588387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic drug monitoring of clozapine and norclozapine in human serum using ultra-performance liquid chromatography- tandem mass spectrometry.
    Ming DS; Heathcote J
    J Anal Toxicol; 2009 May; 33(4):198-203. PubMed ID: 19470221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous determination of clozapine and its N-desmethyl and N-oxide metabolites in plasma by liquid chromatography/electrospray tandem mass spectrometry and its application to plasma level monitoring in schizophrenic patients.
    Aravagiri M; Marder SR
    J Pharm Biomed Anal; 2001 Sep; 26(2):301-11. PubMed ID: 11470207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective study of clozapine and norclozapine concentration in patients with schizophrenia: Data from the Therapeutic Drug Monitoring Service, 2019-2022.
    Ding J; Liu J; Zhang Y; Xing H; Zhang Y; Li L; Zhang S; Wang H; Yang L; Cui X
    Asian J Psychiatr; 2024 Jan; 91():103865. PubMed ID: 38113699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical predictors of serum clozapine levels in patients with treatment-resistant schizophrenia.
    Rajkumar AP; Poonkuzhali B; Kuruvilla A; Jacob M; Jacob KS
    Int Clin Psychopharmacol; 2013 Jan; 28(1):50-6. PubMed ID: 23104241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher plasma drug concentration in clozapine-treated schizophrenic patients with side effects of obsessive/compulsive symptoms.
    Lin SK; Su SF; Pan CH
    Ther Drug Monit; 2006 Jun; 28(3):303-7. PubMed ID: 16778711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between serum clozapine concentrations and hematological parameters by a validated mass spectrometric method.
    Kamil Gharab KM; Onmaz DE; Abusoglu S; Aydin M; Sivrikaya A; Tok O; Abusoglu G; Unlu A
    J Pharm Biomed Anal; 2020 Feb; 180():113056. PubMed ID: 31887669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of clozapine in serum by radioreceptor assay versus high-performance liquid chromatography: possible detection of hydroxy-metabolites.
    Odou P; Frimat B; Fontaine B; Luyckx M; Brunet C; Robert H; Dine T; Gressier B; Cazin M; Cazin JC
    J Clin Pharm Ther; 1996 Oct; 21(5):337-42. PubMed ID: 9119916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective evaluation of therapeutic drug monitoring of clozapine and norclozapine in Belgium using a multidrug UHPLC-MS/MS method.
    Patteet L; Maudens KE; Vermeulen Z; Dockx G; De Doncker M; Morrens M; Sabbe B; Neels H
    Clin Biochem; 2014 Dec; 47(18):336-9. PubMed ID: 25289972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dried Blood Spot Analysis for Therapeutic Drug Monitoring of Clozapine.
    Geers LM; Cohen D; Wehkamp LM; van Hateren K; Koster RA; Fedorenko OY; Semke AV; Bokhan N; Ivanova SA; Kosterink JGW; Loonen AJM; Touw DJ
    J Clin Psychiatry; 2017; 78(9):e1211-e1218. PubMed ID: 29068609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics.
    Spina E; Avenoso A; Facciolà G; Scordo MG; Ancione M; Madia AG; Ventimiglia A; Perucca E
    Psychopharmacology (Berl); 2000 Jan; 148(1):83-9. PubMed ID: 10663421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozapine and norclozapine concentrations in serum and plasma samples from schizophrenic patients.
    Hermida J; Paz E; Tutor JC
    Ther Drug Monit; 2008 Feb; 30(1):41-5. PubMed ID: 18223461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum concentrations of clozapine and norclozapine in the prediction of relapse of patients with schizophrenia.
    Xiang YQ; Zhang ZJ; Weng YZ; Zhai YM; Li WB; Cai ZJ; Tan QR; Wang CY
    Schizophr Res; 2006 Apr; 83(2-3):201-10. PubMed ID: 16524698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma clozapine and norclozapine in relation to prescribed dose and other factors in patients aged <18 years: data from a therapeutic drug monitoring service, 1994-2010.
    Couchman L; Bowskill SV; Handley S; Patel MX; Flanagan RJ
    Early Interv Psychiatry; 2013 May; 7(2):122-30. PubMed ID: 22747759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The significance of sampling time in therapeutic drug monitoring of clozapine.
    Jakobsen MI; Larsen JR; Svensson CK; Johansen SS; Linnet K; Nielsen J; Fink-Jensen A
    Acta Psychiatr Scand; 2017 Feb; 135(2):159-169. PubMed ID: 27922183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring of plasma clozapine levels and its metabolites in refractory schizophrenic patients.
    Liu HC; Chang WH; Wei FC; Lin SK; Lin SK; Jann MW
    Ther Drug Monit; 1996 Apr; 18(2):200-7. PubMed ID: 8721285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum level of clozapine and relapse.
    Ulrich S; Wolf R; Staedt J
    Ther Drug Monit; 2003 Apr; 25(2):252-5. PubMed ID: 12657924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive review of the clinical utility of and a combined analysis of the clozapine/norclozapine ratio in therapeutic drug monitoring for adult patients.
    Schoretsanitis G; Kane JM; Ruan CJ; Spina E; Hiemke C; de Leon J
    Expert Rev Clin Pharmacol; 2019 Jul; 12(7):603-621. PubMed ID: 31075044
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of gender and age on plasma levels of clozapine and its metabolites: analyzed by critical statistics.
    Lane HY; Chang YC; Chang WH; Lin SK; Tseng YT; Jann MW
    J Clin Psychiatry; 1999 Jan; 60(1):36-40. PubMed ID: 10074876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacoclinical strategy in neuroleptic resistant schizophrenic patients treated by clozapine: clinical evolution, concentration of plasma and red blood cell clozapine and desmethylclozapine, whole blood serotonin and tryptophan.
    Aymard N; Viala A; Baldacci C; Smagghe PO; Vacheron MN; Caroli F
    Prog Neuropsychopharmacol Biol Psychiatry; 1999 Jan; 23(1):25-41. PubMed ID: 10368854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.